Authors


Jessica Randolph, Two Labs

Latest:

3PL selection as part of product launch process

The importance of partners being flexible and optimizing their processes in today's virtual climate



Suzanne Shelley, Pharmaceutical Commerce contributing editor

Latest:

Specialty pharmacy accreditation — burden and benefit

Accreditation status is both an entry ticket and a competitive measure for specialty pharmacies to attract manufacturer attention


Steve Gransden, J. Knipper

Latest:

Multi-Channel Marketing Carries Sampling Programs Forward

By combining online with traditional direct-marketing media, manufacturers can accelerate sampling programs even in the face of restricted physician access


Kevin Michels-Kim, The Stem

Latest:

Digital opinion leaders (DOLs) and their role in pharma markets

Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign


Greg Rotz

Latest:

Focusing pharma marketing on 'headroom'

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'


Jonathan Davies, PhD, Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Latest:

Follow-on Biologics: A Patent Litigation Perspective

In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully


Greg Page, Deloitte Consulting LLP

Latest:

Managing quality risks across the pharmaceutical supply chain

Well designed quality systems follow the product life cycle and foster a culture of quality


Tony Dellumo, QProducts & Services

Latest:

Cold chain capacity crisis looms ahead of Covid-19 vaccine rollout. Are you prepared?

Top players from cold chain logistics’ pharma, biologics, and life sciences sector sound alarm on the upcoming burden on temperature-controlled shipping capacity as the global supply chain plans for the safe distribution of Covid-19 vaccines requiring strict temperature management, some as cold as -20 to -30⁰C.


Regina Murphy, McKesson Specialty Care Solutions

Latest:

Dealing With REMS Challenges in Drug Commercialization

Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations



Esin Izat, Beghou Consulting

Latest:

Navigating the patient journey after rare disease diagnosis

Commercial teams can prepare for overcoming predictable hurdles


Arthur G. Cook, ZS Associates

Latest:

Forecasting for the Pharmaceutical Industry

The second edition of an essential business planner's library


Sean McCarthy

Latest:

Strategies for effective patient services programs

Addressing continued hurdles in patient adherence


By Sumeet Singh, Five Rivers RX

Latest:

The current state of suspicious- order monitoring

DEA’s manufacturer and distributor data-collection requirements are changing


Heather Morel

Latest:

Smoothing the Path to Drug Safety

REMS programs need to address stakeholder usability



Angelo De Palma, PhD

Latest:

Feds Elevate Comparative Effectiveness to Address Future Healthcare Development

Evaluating medicine and healthcare by their outcomes is now an NIH priority


Robert Califf, MD

Latest:

Laying the foundation for a national system for evidence generation

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis



Desmond Hunt, PhD

Latest:

Complex supply chains demand a holistic approach to protect patients

The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity


Lindsay Duncan, Cegedim Dendrite

Latest:

Look for Flexibility In Your CRM or SFA System

Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?



Rubik Angelo Barar, Rajat Saxena

Latest:

Vaccine growth spurs device, contract-services markets

A double-digit growth rate through 2024 means boom times for drug-delivery devices and for contract manufacturing services


Dusty Tenney, Stirling UltraCold

Latest:

Meeting the challenges of rapid Covid-19 vaccine cold chain deployment

Ultralow temperatures require a revision of vaccine distribution technology


Don Hannaford, Levick Strategic Communications

Latest:

Transparency Is the Solution to the Medical-Journal 'Ghostwriting' Controversy

Drug companies should keep a goal of effective communications as the priority in medical publications


General Manager of UL Compliance to Performance

Latest:

Managing employee training at the enterprise level

The case for a single enterprise-wide learning management system


Bob Celeste, RCG Partners

Latest:

Does healthcare benefit from a unified approach to item-level serialization and UDI?

"If we had asked them, they would have asked for faster horses." ~ Henry Ford


Paul Keckley, Deloitte Center for Health Solutions

Latest:

Deloitte 2010 Survey of Health Care Consumers

More personal control over healthcare and the desire for more access to information drive consumer attitudes


© 2024 MJH Life Sciences

All rights reserved.